FIELD: organic chemistry, medicine, hematology.
SUBSTANCE: invention relates to novel compounds or their salts that inhibit blood coagulation activated factor X and elicit strong anti-coagulating effect. Compounds are represented by one of the following formulae: Also, invention relates to a medicinal agent, inhibitor of blood coagulation activated factor X, anti-coagulating agent, medicinal composition comprising indicated compounds, to their using for preparing a medicinal agent, inhibitors and anti-coagulating agent.
EFFECT: valuable medicinal properties of compounds.
9 cl, 1 tbl, 794 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF DIAMINES | 2002 |
|
RU2319699C2 |
ETHYLENEDIAMINE DERIVATIVES AND FXa INHIBITOR AND ANTICOAGULANT COMPRISING THEREOF | 2001 |
|
RU2268259C2 |
DIAMINE DERIVATIVES | 2003 |
|
RU2333203C2 |
PHENYLPYRAZOL DERIVATIVES | 2008 |
|
RU2480456C2 |
CYCLOALKANE-1,3-DIAMINE DERIVATIVE | 2019 |
|
RU2793247C2 |
USING EP4 RECEPTOR LIGANDS IN TREATMENT OF IL-6-MEDIATED DISEASES | 2003 |
|
RU2285527C2 |
NEW β-LACTAMASE INHIBITOR AND A METHOD OF ITS PRODUCTION | 2019 |
|
RU2800050C2 |
NOVEL BETA-LACTAMASE INHIBITOR AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2693898C2 |
DERIVATIVES OF 2-IMINOPYRROLIDINE | 2002 |
|
RU2270192C2 |
CYCLOALKYL-SUBSTITUTED IMIDAZOLE DERIVATIVE, POSSESSING INHIBITING ACTIVITY WITH RESPECT TO TAFIa | 2011 |
|
RU2572814C2 |
Authors
Dates
2008-01-10—Published
2002-08-08—Filed